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A bstract
Background: Parasites causing severe malaria in non-immune patients express a restricted subset of 
variant surface antigens (VSA), which are better recognized by immune sera than VSA expressed during 
non-severe disease in semi-immune individuals. The most prominent VSA are the var gene-encoded 
Plasmodium falciparum erythrocyte membrane protein l (PfEMPl) family, which is expressed on the surface 
of infected erythrocytes where it mediates binding to endothelial receptors. Thus, severe malaria may be 
caused by parasites expressing PfEMPl variants that afford parasites optimal sequestration in 
immunologically naive individuals and high effective multiplication rates.
Methods: var gene transcription was analysed using real time PCR and PfEMPl expression by western 
blots as well as immune plasma recognition of parasite cultures established from non-immune volunteers 
shortly after infection with NF54 sporozoites.
Results: In cultures representing the first generation of parasites after hepatic release, all var genes were 
transcribed, but GroupA var genes were transcribed at the lowest levels. In cultures established from 
second or third generation blood stage parasites of volunteers with high in vivo parasite multiplication 
rates, the var gene transcription pattern differed markedly from the transcription pattern of the cultures 
representing first generation parasites. This indicated that parasites expressing specific var genes, mainly 
belonging to group A  and B, had expanded more effectively in vivo compared to parasites expressing other 
var genes. The differential expression of PfEMPl was confirmed at the protein level by immunoblot analysis. 
In addition, serological typing showed that immune sera more often recognized second and third 
generation parasites than first generation parasites.
Conclusion: In conclusion, the results presented here support the hypothesis that parasites causing 
severe malaria express a subset of PfEMPl, which bestows high parasite growth rates in individuals with 
limited pre-existing immunity.
Open Access
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Background
Plasmodium falciparum-encoded variant surface antigens 
(VSA) are expressed on the surface of infected erythrocytes 
(IE) and mediate binding to a range of endothelial cell 
receptors [1]. Endothelial adhesion contributes to the par­
ticular virulence of the P. falciparum and most likely has 
evolved as a mechanism to avoid parasite clearance in  the 
spleen [2-4]. Individuals living in areas of intense parasite 
transmission develop immunity towards severe malaria 
early in life [5]. Parasites causing severe malaria in young 
children with limited pre-existing immunity tend to 
express a limited, relatively conserved subset of VSA 
(VSAsm) that is more often and better recognized by anti­
bodies from m ost parasite-exposed individuals than the 
larger and more diverse VSAUM subset expressed by para­
sites causing uncomplicated malaria [6-8]. It thus appears 
that expression of VSAsm confers a selective advantage in 
non-immune individuals, perhaps by allowing particu­
larly efficacious endothelial sequestration and conse­
quently high effective growth rates. The best characterized 
VSA are the var gene-encoded P. falciparum erythrocyte 
membrane protein 1 (PfEMPl) family [9-11]. Each hap­
loid parasite genome contains 50-60 var genes, of which 
the 59 var genes annotated in the fully sequenced P. falci­
parum clone 3D7 can be divided into three major groups, 
A, B and C, based on sequence analysis [12,13]. The func­
tional relevance of this grouping is supported by the par­
allel differences in CD3 6-binding characteristics of 
PfEMP1 CIDR1a domains. Thus, GroupA CIDR1a 
domains do not bind CD36, whereas CIDR1a domains 
encoded by GroupB and GroupC var genes do [14]. The 
3D 7 PfEMP1 repertoire may well represent the VSAUM - 
VSAsm spectrum observed in field isolates, and recent find­
ings point to GroupA as encoding VSASM-type PfEMP1 
molecules in patient isolates [13,15-17]. Unfortunately, 
little is known about var gene expression in vivo, and stud­
ies have been frustrated by the difficulties in  detecting and 
quantifying expression in  parasites with unknown var 
gene repertoires. This difficulty has been overcome by tak­
ing advantage of the knowledge of the var gene repertoire 
in 3D7 and analyzing var gene expression in NF54 para­
sites (the parental line of 3D7) isolated from non­
immune individuals experimentally infected by mosquito 
challenge. Immediately upon release from the liver, the 
parasites appeared to transcribe all var genes, with 
GroupA genes being the least transcribed. However, 
within one or two parasite generations this pattern 
changed, in  particular in  those parasites exhibiting the 
fastest in vivo growth rates. Here, only a few genes domi­
nated the var transcript population. The data indicate that 
PfEMP1-determined differences in  growth rates shape the 
expressed PfEMP1 repertoire, and that some PfEMP1 var­
iants confer high effective parasite multiplication rates in 
non-immune individuals.
Materials and methods 
Malaria parasites
Parasites were isolated from Dutch volunteers exposed to 
mosquitoes infected with P. falciparum isolate NF54[18] 
as part of ongoing studies of experimental P. falciparum 
infections. On day 0, ten non-immune volunteers were 
subjected to two or five infectious bites. Chloroquine 
treatment was initiated on the first day a thick smear was 
positive. Parasite cultures were established from 400 
microlitres of packed blood cells drawn on days 8, 9, and 
10 and parasites were cultured in vitro for 27 or 33 days 
(Figure 1) to obtain sufficient parasite material for DNA, 
RNA and protein analysis. The parasites were cultured in 
0 Rh+ erythrocytes as described [19], with the addition of 
2% non-immune hum an serum to the culture media. 
Long-term in vitro 3D7 cultures expressing VSAUM-type 
antigens or selected in vitro to express VSASM-type antigens 
were used as controls[20].
DNA, RNA, cDNA and quantitative real-time PCR
The development of parasitaemia was monitored by 
quantitative real-time PCR as described [21]. DNA, RNA 
and cDNA for var gene transcription analysis were pre­
pared from synchronized parasite cultures as described 
[17]. Quantitative real-time PCR was performed using a 
Rotorgene thermal cycler system (Corbett Research, Mot- 
lake, Australia). Real-time PCR-optimized and gene-spe­
cific primers for each of all full-length var genes and a 
pseudogene in  the 3D7 isogenic NF54 P. falciparum 
genome were those described in [22], except for PFI1830c. 
Real time primers for this gene were forward 
5'ACAACAATTTCGCAAGCAAG 3', reverse 5'TTCCTCT- 
GCCTCCTCTTCAT 3'. Standard curves for the estimation 
of product-related fluorescent bias and amplification effi­
ciencies were generated for all primer pairs. For 15 primer 
sets, standard curves were generated both from dilution 
series of genomic DNA and from cloned gene fragments 
[17]. As the two approaches led to identical standard 
curves (not shown), standard curves for the remaining 
genes were determined from genomic DNA only. The 
standard curves were linear across a range of seven logs of 
DNA concentrations (R = 0.9779 to 0.9995) with amplifi­
cation efficiencies between 90 and 101%. Standard curves 
were used for primer bias corrections in  calculations of 
absolute transcript levels. The detection limit of the sys­
tem was > 20 copies. The housekeeping genes seryl-tRNA 
synthetase and fructose-bisphosphate aldolase have uniform 
transcription profiles throughout the parasite life 
cycle[22], and were used as endogenous controls. Differ­
ences in  var transcript distribution between samples were 
calculated by the AA CT m ethod using the endogenous 
controls for normalization.
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A: Parasite densities in the six volunteers from whom parasite isolates were established. Note that parasitaemia scales are dif­
ferent. Closed circles indicate time points where parasite density was determined by PCR. Time points where blood samples 
were cultured successfully are underlined. A  cross indicates time of chloroquine treatment. B: Representation of parasite gen­
eration and stage composition of a P. falciparum infection after liver release. Parasites were first detected on day 6,33. Estimates 
of parasite release from the liver (~24 hours, over all volunteers), duration of circulating stages (l, l8  days) and adhesive stages 
(0,64 days) were taken from reference 24. Time of blood sampling is framed. When sampling blood the early circulating stages 
are isolated, i.e. blood drawn on day 8 predominantly contains first-generation parasites after liver release.
Immunoblot analysis and flow cytometry
Im m unoblot analysis was performed as previously 
described [17]. Flow cytometryand plasma from malaria-
exposed children and adults were used to classify the VSA 
expressed by parasites isolated on days 8, 9 and 10 as pre­
viously described[7,20,23]
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F ig u re2
Var gene transcription profile of NF54 ring-stage parasite cul­
tures established on day 8 from six volunteers. The mean 
transcription levels ± l SD of primer bias-corrected and nor­
malized values of the six cultures are shown relative to the 
overall mean var transcription level. Var gene name and group 
are indicated.
Results
Experimental infections and establishment o f parasite 
culture lines
Successful infections were established in  eight of the 10 
volunteers. Despite low parasitaemias, a total of 13 para­
site culture lines from blood collected from six of the vol­
unteers at three time points after infection were 
established (Figure 1A). The highest parasite growth rates 
were observed in  volunteers 1 and 2 with peak parasitae- 
mias of 13,832 parasites/ml and 4,637 parasites/ml, 
respectively, whereas peak parasitaemias in  all other vol­
unteers were below 1,400 parasites/ml. As recognized 
from previous similar hum an vaccination trials [21], par- 
asitaemias fluctuated in  a distinct manner, probably 
reflecting liver release, sequestration of trophozoite/sch- 
izonts and release of new generations of merozoites from 
schizonts. Parasites obtained on day 8 were predomi­
nantly first-generation blood parasites, assuming that par­
asites were released from the liver between days 6,33 and 
7,33[24] (Figure 1B). Similarly, day9 parasites were 
assumed to represent second-generation parasites, and 
day10 parasites a mixture of second and third generation 
parasites.
Uniform transcription o f  var genes in first-generation 
asexual parasites
The pattern of var gene transcription was surprisingly con­
sistent in  all the six parasite lines obtained on day8 from 
six of the volunteers (Figure 2). Transcripts of all var genes 
could be detected in  ring-stage cultures, and most were 
transcribed at roughly similar levels. Interestingly, nine of 
the 10 lowest transcribed genes belonged to var subgroup 
A or B/A, which have previously been associated with 
severe malaria [13]. In agreement with previous studies 
[17] all var genes were transcribed at markedly lower lev­
els in  thetrophozoite/schizont-stage compared to ring­
stage parasites (data not shown). The pseudo-gene 
PFE1640w (var1) behaved differently and was expressed at 
similar levels by late stage parasites, comprising approxi­
mately 20% of the total number of var gene transcripts in 
trophozoite-stage parasites (data not shown).
M arked changes in the var gene transcription patterns 
from the first to the second and third generations o f  
asexual parasites
The var gene transcription patterns of the five isolates 
obtained on day9 and the two obtained at day10 were dif­
ferent from those of the day8 isolates, in particular in the 
isolates obtained from volunteers 1 and 2 in  whom high 
parasite growth was observed (Figure 1 and 3). Ring-stage 
parasites from volunteer 1 showed remarkably large tran­
scriptional changes for five var genes. Four (PF11_0008, 
PFD1235w, MAL6P1.1, MAL7P1.55) were transcribed at 
much higher (>20-fold) and one gene (PFA0015c) at 
markedly lower levels (12-fold) in the day 10 isolate
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Fold difference in var gene transcription between NF54 ring-stage parasites isolated from the same volunteer on different days. 
Genes are sorted by gene groups as defined in [l3]. Note that the fold-change scale for volunteer l is different from the other 
panels. Vertical dashed lines mark an arbitrarily defined two-fold cut off value for biologically significant changes in var gene 
transcription. Experiments with volunteer l were repeated three times and results are shown as means ± SD.
compared to the day8 isolate. The estimation of absolute 
copy numbers (not shown) revealed that PF11_0008, 
MAL6P1.1 and MAL7P1.55 were the three highest tran­
scribed var genes in  the day10 isolate, comprising approx­
imately 22%, 40% and 8% of all var transcripts, 
respectively. The abovementioned five genes also showed 
the most pronounced changes in gene transcription (10­
20 fold) when trophozoite stage parasites from days 8 and 
10 were compared. The most prom inent change among 
ring-stage parasites from volunteer 2 was the 15-fold 
increased transcription of PFD0020c, which was the high­
est (~8%) transcribed var gene in the day 9 isolate (Figure 
3). Only m inor changes in var gene transcription patterns 
between days 8 and 9/10 were observed in the parasites 
isolated from volunteer 4, 6 and 10.
Overall, none of the var genes had a consistently altered 
transcript proportion in  all volunteers. However, tran­
scription of seven genes (PFD0005w, PFD0020c, 
PFD1235w, MAL6P1.1, PF10_0406, PF11_0007 and
PFL0005w) increased in more than one volunteer, 
whereas transcription of three genes (PFA0015c, 
MAL6P1.4 and PFE1640w) decreased in more than one 
volunteer (Figure 3). In general, analysis of ring-stage and 
trophozoite/schizont-stage parasites yielded similar 
results.
Expected changes in PfEMPl  expression between first, 
second and third generation asexual parasites were 
confirmed by western blot analysis
To investigate PfEMP1 translation in the 13 isolates, west­
ern blot analysis were performed on protein extractions of 
trophozoite/schizont-stage cultures using rabbit and 
murine antisera raised against the conserved acidic termi­
nal segment (ATS) and against DBL58 of PFD1235w, 
respectively (Figure 4). The analysis of parasites from vol­
unteer 1 revealed differential expression from day8 to 
day10 (Figure 4A). Thus, a high molecular weight band of 
around 400 kDa was seen only in the day 10 culture when 
using the ATS-specific antibody (Figure 4A). This band
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Figure 4
PfEMPl expression in trophozoite-stage cultures of unselected 3D7 (3D7UM), 3D7 selected for expression of VSASM-type IE 
surface antigens (3D7SM) and of NF54 established from six volunteers on different days after infection. A: Western blot using 
antibodies (aATS) targeting the acidic terminal segment (ATS), which is conserved between most PfEMPl types. Black arrows 
indicate changes in protein expression between isolates of the same volunteer. B: Western blot identifying the aATS-detected 
400 kDa band in the day l0 culture of volunteer l as PFDl235w/VAR4 using an aDBL58 antibody. VAR4 is expressed on the 
surface of the 3D7SM line selected for high immune serum recognition [l7].
size corresponds to the expected size of PFD1235w, which 
also exhibited a large increase in  transcription from day8 
to day10 among parasites from this donor, and its identity 
was confirmed using the PFD1235w DBL58 antibody 
(Figure 4B). PFD1235w could no t be detected in any of 
the other cultures, although small increases in  transcrip­
tion were found in several of the cultures (not shown). 
Two bands of 350 kDa and 260 kDa were particularly 
intense in the day10 culture of volunteer 1 (Figure 4A). 
This finding correlates with the expected sizes and ele­
vated transcription of PF11_0008 (345 kDa), MAL6P1.1 
and MAL7P1.55 (both ~258 kDa). Transient bands at 
around 230 kDa and 310 kDa appeared to emerge on day 
9 and disappear on day 10 in  the cultures of volunteer 1. 
No obvious identity could be assigned to these proteins. 
In the remaining cultures, differential PfEMP1 expression 
detected by the ATS antibody was found in  volunteers 6 
and 10. In both cases a band of 310 kDa was observed in 
day10 and 9 parasites, respectively. The best candidate 
gene for this band is PFD0005c, which is predicted to have 
the observed size and was found to be more highly tran­
scribed in  the these cultures. All day 8 cultures were very 
similar and all appeared to dominantly express PfEMP1s 
around 260 kDa, which corresponds to the expected sizes
of the highest transcribed genes in these cultures (figure 
2).
Second and third generation parasites express VSA that 
are recognized more frequently by immune plasma than 
first generation parasites
The VSA phenotype of parasites can be classified relative 
to each other and in the spectrum between VSAsm and 
VSAum, depending on the proportion of individuals from 
an endemic area that possess antibodies to the expressed 
VSA [7,20]. To establish their VSA phenotype, the serolog­
ical recognition of the isolated NF54 parasites was tested 
using a panel of plasma obtained from children and 
adults living in Coastal Ghana (Figure 5). All day 8 para­
site isolates, representing the first generation of asexual 
blood-stage parasites, expressed VSA that were recognized 
by IgG in plasma samples from only a minority of the 
children and from about half of the adults (Figure 5). 
These parasites were also less well recognized than the 
standard 3D7 VSAUM line, which dominantly expresses 
PfEMP1 encoded by GroupC var genes. The seven lines 
isolated on days 9 or 10 all expressed VSA that were more 
frequently recognized than the corresponding day8 line 
(P = 0.01, Wilcoxon signed-ranked test). This trend was
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Plasma recognition profiles of trophozoite-stage cultures of 
NF54 established from six volunteers on different days after 
infection. Profiles of unselected 3D7 (UM) and 3D7 selected 
in vitro for expression of VSASM-type IE surface antigens (SM) 
are shown for comparison. Recognition was measured by 
flow cytometry using IgG from Ghanaian adults and children 
(see Materials and Methods). Filled boxes indicate mean 
FITC-fluorescenceindex (MFI)abovea cut-off defined by the 
mean + 2 standard deviations of 8 Danish control plasma.
particularly clear for the day9/10 lines from volunteers 1,
2 and 10, which were recognized by all of the plasma sam­
ples from adults and from the majority of the children, 
similarly to the recognition of 3D7 selected for expression 
of VSASM-type IE surface antigens (Figure 5). However, 
quantitatively the serum recognition of all isolates was 
lower than that of the 3D7SM line (data not shown). The 
3D 7 VSAsm line has been selected for VSAsm expression 
using IgG from semi-immune children and dominantly 
expresses the product of PFD1235w (VAR4) on the surface 
on infected erythrocytes. Interestingly, parasites from vol­
unteers 1, 2 and 10 had an increased transcription of a
particular var gene (PFD1235w; var4) (Figure 2) as does 
3D7 in response to selection for VSAsm expression[17].
Discussion
The inter- and intra-clonal variability of the var genes have 
frustrated attempts to investigate the roles of the encoded 
PfEMPl proteins in pathogenesis and protection. The 
m ost common strategy has been to quantify var transcrip­
tion by counting the frequency of unique sequence tags, 
amplified by degenerate primers targeting semi-conserved 
blocks of DBL domains. This has been used to study phe­
notypically distinct laboratory lines [10,25-29]and para­
site strains isolated from patients with defined clinical 
outcomes [16,30-32] The only previous study of var gene 
transcription in  experimentally infected humans also 
applied this strategy [33]. However, it requires the 
sequencing of a large number of clones for statistical sig­
nificance and is inherently susceptible to primer bias. 
Together, this makes data interpretation difficult. To over­
come these difficulties, sensitive and gene-specific tools 
were used to analyse in  detail the pattern and dynamics of 
var gene expression in  non-immune volunteers infected 
with a parasite with a known var gene repertoire. The 
necessity for in vitro expansion of parasites from blood 
samples with submicroscopic parasitaemias makes this 
approach susceptible to two separate types of bias. Firstly, 
cultures were established from a relatively small number 
of parasites and the transcription profiles of these para­
sites may not represent the profile of the entire in vivo pop­
ulation. However, in  most cultures the founder 
population was between 100 and 4,000 parasites, and 
only two cultures, which did not exhibit biased transcrip­
tion patterns (day 8 culture of volunteers 1 and 4) were 
established from less than 100 parasites. Secondly, P. fal­
ciparum has been reported to switch var gene expression at 
variable rates in vitro [34,35]. Hence, the var gene expres­
sion in  the cultures at the time of transcription analysis 
may not reflect the expression profile in vivo at the time of 
blood collection. The transcription profiles of the cultures 
isolated on day 8 were similar and different to the profiles 
of the parasites isolated on days 9 and 10. This, and the 
fact that the differential var gene transcription, translation 
and serological recognition of PfEMP1 correlated with 
parasite growth, however, indicates that in vitro switching 
did not invalidate the analyses.
No var gene was dominantly transcribed in the day 8 cul­
tures. Instead, a relatively large group of genes belonging 
to var groups B and C were expressed at almost similar lev­
els and interestingly, nine of the 10 lowest transcribed 
genes belonged to group A or B/A. These data imply that 
the PfEMP1 expression pattern at the beginning of the 
infection is broad and anticipatory. In addition, the con­
sistent increase in  recognition by immune sera with time 
of infection and the apparent association between high
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growth rates and differential expression of a few group A 
and B genes from first to second and third generation 
imply that it is the host environment that modulates the 
PfEMP1 expression. This is a plausible scenario because of 
the large and immediate differences in  survival fitness that 
are likely to be imposed on the asexual parasites by the 
physiology and pre-existing immunity of the host. While 
most -  or all -  of the PfEMP1 variants that can be 
expressed by a given parasite will be exposed to the 
immune system according to this model, the majority of 
the variants are likely to be present too briefly to induce a 
significant immune response. Crucially, survival fitness 
differences depend on which PfEMP1 variants are being 
expressed and necessitate a parasite response much faster 
than which can be achieved by switching to advantageous 
var genes. Although differences in switching rates can con­
tribute to the pattern of var gene expression [35] and may 
well be responsible for the differences in  transcription 
observed on day 8 (Figure 2), differences in survival rates 
may be far more im portant in  focusing and ordering 
PfEMP1 expression in vivo. In non-immune individuals 
this process would be expected to focus expression on the 
restricted and relatively conserved subset of VSA (VSAsm) 
associated with severe disease in  patients with little pre­
existing immunity [13,17] It has previously been docu­
mented that in vitro selection of 3D7 for acquisition of the 
VSAsm phenotype is associated with expression of a subset 
of var genes [[15]. Strikingly, four of the five marked dif­
ferentially transcribed genes (PF11_0008, PFD1235w, 
MAL7P1.55 and PFA0015c) in the volunteer 1 cultures, 
were among the few genes differentially transcribed genes 
upon selection for the 3D7SM phenotype, in which there 
was selection for expression of PF11_0008, PFD1235w 
and MAL7P1.55 and against expression of PFA0015.
In the study of Peters et al [33] the clone frequency strat­
egy was used to investigate var transcription profiles of 
parasites isolated from two volunteers on day 12 and 13 
after infection with 3D7 by eight or nine infectious mos­
quito bites. One transcript, PF11_0007, belonging to var 
group B, comprised half of the 39 and 41 sequences 
cloned from the two volunteers respectively. In total 10 
and nine different var tags were found and only one 
belonged to var group A. The parasites were predicted to 
be 3rd or 4th generation and the parasitaemias in  the two 
volunteers were 18,000 and 212,000 parasites/ml. Thus, 
these profiles are best compared with that of the day 10 
isolate of volunteer 1 presented in  this study. Taking into 
account the potential ambiguities in  the interpretation of 
the results presented by Peters et al, we believe that the 
two data sets could reflect similar dynamics in  the hum an 
host.
Conclusion
In conclusion, the data -  in combination with earlier find­
ings -  suggest that PfEMP1 expression is determined and 
ordered mainly by host physiology and immunity, and 
that this will cause infections in  non-immune individuals 
to be dominated by VSASM-type variants such as those 
encoded by Group A and B var genes.
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